News
Despite these clinical milestones and ongoing innovation, including first-in-human studies of new oncology drugs, Pfizer Inc.
On May 22, 2025, the U.S. Federal Trade Commission (FTC) withdrew its administrative case opposing Microsoft Corporation (NASDAQ:MSFT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback